These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35460870)

  • 21. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease.
    Fernández-García S; Orlandi JG; García-Díaz Barriga GA; Rodríguez MJ; Masana M; Soriano J; Alberch J
    BMC Biol; 2020 May; 18(1):58. PubMed ID: 32466798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.
    Franciosi S; Ryu JK; Shim Y; Hill A; Connolly C; Hayden MR; McLarnon JG; Leavitt BR
    Neurobiol Dis; 2012 Jan; 45(1):438-49. PubMed ID: 21946335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease.
    Ghilan M; Bostrom CA; Hryciw BN; Simpson JM; Christie BR; Gil-Mohapel J
    Brain Res; 2014 Sep; 1581():117-28. PubMed ID: 24949563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Water-Reaching Platform for Longitudinal Assessment of Cortical Activity and Fine Motor Coordination Defects in a Huntington Disease Mouse Model.
    Wang Y; Sepers MD; Xiao D; Raymond LA; Murphy TH
    eNeuro; 2023 Jan; 10(1):. PubMed ID: 36596592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.
    Teo RT; Hong X; Yu-Taeger L; Huang Y; Tan LJ; Xie Y; To XV; Guo L; Rajendran R; Novati A; Calaminus C; Riess O; Hayden MR; Nguyen HP; Chuang KH; Pouladi MA
    Hum Mol Genet; 2016 Jul; 25(13):2621-2632. PubMed ID: 27126634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease.
    Southwell AL; Franciosi S; Villanueva EB; Xie Y; Winter LA; Veeraraghavan J; Jonason A; Felczak B; Zhang W; Kovalik V; Waltl S; Hall G; Pouladi MA; Smith ES; Bowers WJ; Zauderer M; Hayden MR
    Neurobiol Dis; 2015 Apr; 76():46-56. PubMed ID: 25662335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
    Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
    J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice.
    Dau A; Gladding CM; Sepers MD; Raymond LA
    Neurobiol Dis; 2014 Feb; 62():533-42. PubMed ID: 24269729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.
    Chen X; Wu J; Lvovskaya S; Herndon E; Supnet C; Bezprozvanny I
    Mol Neurodegener; 2011 Nov; 6():81. PubMed ID: 22118545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.
    Wu J; Ryskamp D; Birnbaumer L; Bezprozvanny I
    J Huntingtons Dis; 2018; 7(1):35-50. PubMed ID: 29480205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.
    Cummings DM; Cepeda C; Levine MS
    ASN Neuro; 2010 Jun; 2(3):e00036. PubMed ID: 20585470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease.
    Garcia-Miralles M; Yusof NABM; Tan JY; Radulescu CI; Sidik H; Tan LJ; Belinson H; Zach N; Hayden MR; Pouladi MA
    Mol Neurobiol; 2019 Jun; 56(6):4464-4478. PubMed ID: 30334188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Pearson J; Bailey CD; Rogers DA; Johnson GV; Hayden MR; Leavitt BR
    J Neurochem; 2005 Oct; 95(1):210-20. PubMed ID: 16181425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease.
    de Paula Nascimento-Castro C; Wink AC; da Fônseca VS; Bianco CD; Winkelmann-Duarte EC; Farina M; Rodrigues ALS; Gil-Mohapel J; de Bem AF; Brocardo PS
    Neural Plast; 2018; 2018():4056383. PubMed ID: 30186318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice.
    Wong BKY; Ehrnhoefer DE; Graham RK; Martin DDO; Ladha S; Uribe V; Stanek LM; Franciosi S; Qiu X; Deng Y; Kovalik V; Zhang W; Pouladi MA; Shihabuddin LS; Hayden MR
    Neurobiol Dis; 2015 Apr; 76():24-36. PubMed ID: 25583186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficit in Motor Skill Consolidation-Dependent Synaptic Plasticity at Motor Cortex to Dorsolateral Striatum Synapses in a Mouse Model of Huntington's Disease.
    Glangetas C; Espinosa P; Bellone C
    eNeuro; 2020; 7(2):. PubMed ID: 32144144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.